Wu R - Search Results

1

Focal ablation therapy presents promising results for selectively localized prostate cancer patients.

Feng D, Li D, Xiao Y, Wu R, Wang J, Zhang C. Feng D, et al. Among authors: wu r. Chin J Cancer Res. 2023 Aug 30;35(4):424-430. doi: 10.21147/j.issn.1000-9604.2023.04.08. Chin J Cancer Res. 2023. PMID: 37691892 Free PMC article.

2

Lymphocyte-to-Monocyte Ratio (LMR) During Induction Is a Better Predictor Than Preoperative LMR in Patients Receiving Intravesical Bacillus Calmette -Guerin for Non-Muscle-Invasive Bladder Cancer.

Li DX, Wang XM, Feng DC, Zhang FC, Wu RC, Shi X, Chen K, Bai Y, Han P. Li DX, et al. Front Oncol. 2022 Jul 12;12:937638. doi: 10.3389/fonc.2022.937638. eCollection 2022. Front Oncol. 2022. PMID: 35903700 Free PMC article.

3

Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor.

Wu R, Li D, Zhang F, Bai Y, Wang X, Han P. Wu R, et al. Front Surg. 2022 May 23;9:907485. doi: 10.3389/fsurg.2022.907485. eCollection 2022. Front Surg. 2022. PMID: 36034368 Free PMC article.

4

Li DX, Feng DC, Wang XM, Wu RC, Zhu WZ, Chen K, Han P. Li DX, et al. Eur J Med Res. 2023 Feb 2;28(1):55. doi: 10.1186/s40001-023-01012-x. Eur J Med Res. 2023. PMID: 36732869 Free PMC article.

5

Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.

Wang X, Bai Y, Zhang F, Li D, Chen K, Wu R, Tang Y, Wei X, Han P. Wang X, et al. Among authors: wu r. Front Immunol. 2023 Mar 17;14:955949. doi: 10.3389/fimmu.2023.955949. eCollection 2023. Front Immunol. 2023. PMID: 37006317 Free PMC article.

6

Identification of endothelial-related molecular subtypes for bladder cancer patients.

Li DX, Feng DC, Shi X, Wu RC, Chen K, Han P. Li DX, et al. Front Oncol. 2023 Mar 21;13:1101055. doi: 10.3389/fonc.2023.1101055. eCollection 2023. Front Oncol. 2023. PMID: 37025597 Free PMC article.

7

Transmembrane protein 132A (TMEM132A) predicts overall survival for bladder cancer patients.

Wu R, Li D, Feng D, Han P. Wu R, et al. Asian J Surg. 2023 Sep;46(9):3804-3806. doi: 10.1016/j.asjsur.2023.03.116. Epub 2023 Apr 13. Asian J Surg. 2023. PMID: 37061380 Free article. No abstract available.

8

Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium.

Feng D, Li D, Wu R, Han P. Feng D, et al. Among authors: wu r. Aging Dis. 2023 Dec 1;14(6):1953-1957. doi: 10.14336/AD.2023.0502. Aging Dis. 2023. PMID: 37199595 Free PMC article. No abstract available.

9

Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients.

Feng D, Li L, Li D, Wu R, Zhu W, Wang J, Ye L, Han P. Feng D, et al. Among authors: wu r. Eur J Med Res. 2023 Jul 22;28(1):245. doi: 10.1186/s40001-023-01215-2. Eur J Med Res. 2023. PMID: 37480146 Free PMC article.

10

Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy.

Feng D, Wang J, Li D, Wu R, Wei W, Zhang C. Feng D, et al. Among authors: wu r. Discov Oncol. 2023 Aug 25;14(1):155. doi: 10.1007/s12672-023-00777-1. Discov Oncol. 2023. PMID: 37624511 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,027 results

Search Page

Filters